2024
Summit Proceedings Manuscript
Hardy CSC, Bahr LE, Rothman AL, Anderson KB, Barba-Spaeth G, Weiskopf D, Ooi EE, Marques ETA, Bonsignori M, Barrett ADT, Kirkpatrick BD, Castanha PMS, Hamins-Puertolas M, Christofferson RC, Dimopoulos G, Oliveira F, Chiang LW, Ko AI, Gunale B, Kulkarni P, Perkins TA, Dorigatti I, Stewart T, Shaw J, Johansson MA, Thomas SJ, Waickman AT. Proceedings of the second annual dengue endgame summit: A call to action. PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013028. doi: 10.1371/journal.pntd.0013028. PMID: 40294026; PMCID: PMC12036847.
Agenda 2024
Summit Recordings
Welcome and introductions: 2024 dengue endgame summit
Stephen Thomas
Welcome, and the current state of dengue
Jeremy Farrar
Deciphering the signal in the noise for DENV immunity through long-term cohorts
Kathryn Anderson
Cross-reactivity between flavivirus specific T cells
Daniela Weiskopf:
BCR-dependent enhancement of dengue virus infection
Adam Waickman
Dengue: confronting the pandemic
Scott Halstead
Regulatory considerations for models for dengue vaccine evaluation
Kirk Prutzman
Lessons Learned from the Dengue Human Infection Model Consortium
Stephen Thomas
Use of human challenge models for vaccine evaluation
Beth Kirkpatrick
Discovery of Biomarkers via Epitope Surrogate Technology
Priscila Da Silva Castanham
Vectors and vector control: historical challenges and modern solutions
Rebecca Christofferson
Human SIRT2, an intrinsic immunity target for medical countermeasure development
Lillian Chiang
Sustainable control of DENV will require coordinated deployment of multiple approaches
Alex Perkins
From Doubt to Trust: Strategies to Combat Vaccine Hesitancy in the United States
Jana Shaw
Challenges and opportunities in modeling dengue interventions
Ilaria Dorigatti
Dengue Vaccines - Asian Perspectives
Hoe Nam Leong
Hotel Saranac – Saranac Lake, NY
and the
Trudeau Institute
